热门资讯> 正文

Quince Therapeutics偿还了1600万美元EIB债务;股价飙升18%

2026-03-30 21:45

Quince Therapeutics, Inc.(QNCX) 0

Quince Therapeutics (QNCX) settled its outstanding ~$16.4M EIB loan at a discounted payoff of $5.5M, reducing its debt balance sheet.
CEO & CMO Dirk Thye said the company had settled its EIB debt to allow more flexibility to explore options like mergers, asset sales, or other deals to enhance shareholder value.
As of March 30, 2026, Quince Therapeutics (QNCX) is trading at $0.10, up 18.61%.

More on Quince Therapeutics

Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential
Seeking Alpha’s Quant Rating on Quince Therapeutics
Historical earnings data for Quince Therapeutics
Financial information for Quince Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。